# Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）

> **NCT05281549** · PHASE2 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 225 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Alteplase
- **DRUG:** Tenecteplase
- **DRUG:** Tenecteplase

## Key facts

- **NCT ID:** NCT05281549
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-02
- **Primary completion:** 2022-01-28
- **Final completion:** 2022-05-31
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05281549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05281549, "Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05281549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*